✉news TechnologyAI first seen 20 h ago, last 20 h ago, peak #26
AI Is Reshaping Therapeutic Antibody Design
Original: AI And Therapeutic Antibody Design
Forbes examines how artificial intelligence is transforming the design of therapeutic antibodies, the lab-made proteins behind many modern medicines. AI tools are being used to predict antibody structures, optimise binding and shorten development timelines for new drug candidates. The article reflects growing pharma interest in machine learning to cut costs and speed up the pipeline of antibody-based therapies.
Why now: AI is a fast-moving topic in drug development, drawing attention to its practical role in designing antibody therapies.
Forbesartificial intelligencetherapeutic antibodiespharmaceutical industry
Evidence
- AI And Therapeutic Antibody Design · forbes.com
API: https://socialmediatrends-api.osmike.com/v1/trends/749807